P38蛋白作为败血症诱导的器官功能障碍的治疗靶点

IF 4.2 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Shan Miao , Rui Zhang , Guiping Guo , Xinshang Wang , Bin Zhang , Long Li , Jin Wang , Yan Weng , Xiaopeng Shi , Shanbo Ma , Chenxi Lu
{"title":"P38蛋白作为败血症诱导的器官功能障碍的治疗靶点","authors":"Shan Miao ,&nbsp;Rui Zhang ,&nbsp;Guiping Guo ,&nbsp;Xinshang Wang ,&nbsp;Bin Zhang ,&nbsp;Long Li ,&nbsp;Jin Wang ,&nbsp;Yan Weng ,&nbsp;Xiaopeng Shi ,&nbsp;Shanbo Ma ,&nbsp;Chenxi Lu","doi":"10.1016/j.ejphar.2025.177833","DOIUrl":null,"url":null,"abstract":"<div><div>Sepsis is a systemic disorder with a dysregulated host response caused by infection and is associated with multiple organ dysfunction and a high risk of mortality. Several factors are involved in the complex pathophysiological process of sepsis, including the inflammatory response, immune response, mitochondrial dysfunction, and coagulation cascade. p38 proteins, a class of mitogen-activated protein kinases, play key roles in inflammatory/immune responses and are involved in essential cellular processes. Previous studies have shown that p38 is highly expressed in sepsis and sepsis-induced organ damage and is involved in complex biological, signaling-driven processes. Therefore, this review aims to summarize the efficacy and mechanism of action of p38 in treating sepsis and sepsis-induced multiple-organ damage. First, the basic structure, signal transduction mechanism of p38, and its role in the pathological process of sepsis are comprehensively described. Second, the mechanism of p38 in sepsis-induced multiple-organ damage (including the heart, liver, lung, and brain) is described. Finally, the discovery and application of p38 inhibitors and the role of p38 in sepsis is discussed. This review provides a new therapeutic target for sepsis-induced multiple-organ dysfunction.</div></div>","PeriodicalId":12004,"journal":{"name":"European journal of pharmacology","volume":"1002 ","pages":"Article 177833"},"PeriodicalIF":4.2000,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"p38 protein as a therapeutic target for sepsis-induced organ dysfunction\",\"authors\":\"Shan Miao ,&nbsp;Rui Zhang ,&nbsp;Guiping Guo ,&nbsp;Xinshang Wang ,&nbsp;Bin Zhang ,&nbsp;Long Li ,&nbsp;Jin Wang ,&nbsp;Yan Weng ,&nbsp;Xiaopeng Shi ,&nbsp;Shanbo Ma ,&nbsp;Chenxi Lu\",\"doi\":\"10.1016/j.ejphar.2025.177833\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Sepsis is a systemic disorder with a dysregulated host response caused by infection and is associated with multiple organ dysfunction and a high risk of mortality. Several factors are involved in the complex pathophysiological process of sepsis, including the inflammatory response, immune response, mitochondrial dysfunction, and coagulation cascade. p38 proteins, a class of mitogen-activated protein kinases, play key roles in inflammatory/immune responses and are involved in essential cellular processes. Previous studies have shown that p38 is highly expressed in sepsis and sepsis-induced organ damage and is involved in complex biological, signaling-driven processes. Therefore, this review aims to summarize the efficacy and mechanism of action of p38 in treating sepsis and sepsis-induced multiple-organ damage. First, the basic structure, signal transduction mechanism of p38, and its role in the pathological process of sepsis are comprehensively described. Second, the mechanism of p38 in sepsis-induced multiple-organ damage (including the heart, liver, lung, and brain) is described. Finally, the discovery and application of p38 inhibitors and the role of p38 in sepsis is discussed. This review provides a new therapeutic target for sepsis-induced multiple-organ dysfunction.</div></div>\",\"PeriodicalId\":12004,\"journal\":{\"name\":\"European journal of pharmacology\",\"volume\":\"1002 \",\"pages\":\"Article 177833\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-06-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0014299925005874\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014299925005874","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

脓毒症是一种由感染引起的宿主反应失调的全身性疾病,与多器官功能障碍和高死亡率有关。脓毒症复杂的病理生理过程涉及多个因素,包括炎症反应、免疫反应、线粒体功能障碍、凝血级联等。P38蛋白是一类丝裂原活化蛋白激酶,在炎症/免疫反应中起关键作用,并参与必要的细胞过程。先前的研究表明,p38在脓毒症和脓毒症诱导的器官损伤中高度表达,并参与复杂的生物信号驱动过程。因此,本文就p38在脓毒症及脓毒症引起的多脏器损伤中的作用及机制进行综述。首先,全面阐述p38的基本结构、信号转导机制及其在脓毒症病理过程中的作用。其次,描述了p38在败血症诱导的多器官损伤(包括心、肝、肺和脑)中的机制。最后讨论了p38抑制剂的发现和应用,以及p38在脓毒症中的作用。这一综述为脓毒症引起的多器官功能障碍提供了新的治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
p38 protein as a therapeutic target for sepsis-induced organ dysfunction
Sepsis is a systemic disorder with a dysregulated host response caused by infection and is associated with multiple organ dysfunction and a high risk of mortality. Several factors are involved in the complex pathophysiological process of sepsis, including the inflammatory response, immune response, mitochondrial dysfunction, and coagulation cascade. p38 proteins, a class of mitogen-activated protein kinases, play key roles in inflammatory/immune responses and are involved in essential cellular processes. Previous studies have shown that p38 is highly expressed in sepsis and sepsis-induced organ damage and is involved in complex biological, signaling-driven processes. Therefore, this review aims to summarize the efficacy and mechanism of action of p38 in treating sepsis and sepsis-induced multiple-organ damage. First, the basic structure, signal transduction mechanism of p38, and its role in the pathological process of sepsis are comprehensively described. Second, the mechanism of p38 in sepsis-induced multiple-organ damage (including the heart, liver, lung, and brain) is described. Finally, the discovery and application of p38 inhibitors and the role of p38 in sepsis is discussed. This review provides a new therapeutic target for sepsis-induced multiple-organ dysfunction.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.00
自引率
0.00%
发文量
572
审稿时长
34 days
期刊介绍: The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems. The scope includes: Behavioural pharmacology Neuropharmacology and analgesia Cardiovascular pharmacology Pulmonary, gastrointestinal and urogenital pharmacology Endocrine pharmacology Immunopharmacology and inflammation Molecular and cellular pharmacology Regenerative pharmacology Biologicals and biotherapeutics Translational pharmacology Nutriceutical pharmacology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信